SFCC Sfbc (MM)

SFBC International, Inc. (NASDAQ:SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, will host a listen-only Webcast of its investor meeting at 3:00 p.m. Eastern Time on Thursday, February 2, 2006. The company stated that the primary intent of the meeting is to allow investors to meet Jeffrey McMullen, the recently appointed chief executive officer of SFBC. The company will not be providing any financial information or updates during the meeting. The company cannot accommodate any additional investors at the meeting location; therefore, the meeting is being Webcast as a courtesy to those investors who are not able to attend in person. The listen-only Webcast will be available at http://www.sfbci.com. A replay of the live Webcast will also be available at http://www.sfbci.com approximately two hours after the live call ends through March 2, 2006 at 11:59 p.m. Eastern Time. About SFBC International, Inc. SFBC International, Inc. provides early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe (including Central and Eastern Europe), South America, Asia, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, central laboratory services, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at http://www.sfbci.com.